This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Cases and Commentaries in Atopic Dermatitis

Cases and Commentaries in Atopic Dermatitis

Format

Patient Case Study

Time to Complete

40 minutes

Released

August 22, 2019

Expires

August 22, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider

This activity is jointly provided by Global Education Group and FACTORx in partnership with National Eczema Association.

Commercial Supporter

This activity is supported by an educational grant provided by Pfizer.

Program Description

Atopic dermatitis (AD) or atopic eczema, is a chronic, relapsing, pruritic, inflammatory skin disorder that is the most common chronic inflammatory disease. Individualized therapy for the AD patient should be implemented according to patient’s age, severity of the illness, and its extent and distribution. The intensity of management and treatment of AD is dictated directly by the severity of illness, which relates to the effect of AD on the quality of life of the patient and his or her family. This case study follows the course and management of AD in a patient throughout her life, and includes a discussion between the patient, her primary care clinician, and AD experts. The discussion includes diagnosis, management at different ages, flares, comorbid conditions, and the availability of newer therapeutic options.

Intended Audience

The target audience for this initiative includes allergists (pediatric and adult), dermatologists (pediatric and adult), pediatricians, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare providers involved in the care and management of patients with atopic dermatitis, as well as patients with atopic dermatitis.

Educational Objectives

At the conclusion of this educational activity, participants should be able to:

  • Describe the importance of early recognition, diagnosis, and intervention of AD to minimize the impact of the disease and improve patient quality of life
  • Differentially diagnose mild, moderate, and severe AD patients to guide treatment and referral strategies
  • Discuss AD comorbidities and their proper management
  • Explain the benefits of patient and caregiver education and shared decision-making to improve the effectiveness of therapy and patient compliance with disease management strategies

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Jennifer LeBovidge, PhD
Psychologist, Atopic Dermatitis Center and Food Allergy Program
Boston Children's Hospital
Assistant Professor of Psychology
Harvard Medical School
Boston, MA

Dr. LeBovidge discloses the following:
Clinical Research: Pfizer, Inc.

Robert Sidbury, MD, MPH
Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Children's Hospital
University of Washington School of Medicine
Seattle, WA

Dr. Sidbury discloses the following:
Clinical research: Regeneron (Investigator, no direct financial support) Institution contracts

Megan O. Lewis, MSN, RN, CPNP-PC
Pediatric Nurse Practitioner
Children's Hospital of Philadelphia
Division of Allergy and Immunology
Philadelphia, PA

Ms. Lewis discloses the following:
Advisor or Consultant: DBV Technologies

Paul Doghramji, MD, FAAFP
Senior Family Physician
Collegeville Family Practice
Medical Director
Ursinus College
Collegeville, PA

Dr. Doghramji has nothing to disclose.

Raelle Brown
Patient

Raelle Brown has nothing to disclose.

Accredited Provider Discosures

Ashley Marostica, RN, MSN, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Liddy Knight has nothing to disclose.
Ashley Cann has nothing to disclose.

Publishing Staff Disclosures

Dan Duch, PhD, has nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and FACTORx. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and FACTORx do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Term of Offering

This activity was released on 8/31/19 and is valid for one year. Requests for credit must be made no later than 8/31/20.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue


Related to this activity